Table 4.
Thromboembolic (TE) lower term events followed up.
| Follow-up | ||||||||
|---|---|---|---|---|---|---|---|---|
| Sex | ||||||||
| Event | Total number of all events | Total number reported* | Follow-up response | Female | Male | Age, median (IQR) years | Risk factors present for TE (≥ 1)†‡ | On concomitant anticoagulant‡ |
| Cerebrovascular accident | 56 | 40 | 25/35 (71%)§ | 18 | 7 | 78 (71, 86) | 21 | 12 |
| Transient ischaemic attack | 30 | 24 | 22/24 (92%)¶ | 17 | 4 | 75 (66, 79) | 17 | 12 |
| Myocardial infarction | 37 | 24 | 17/19 (84%)** | 7 | 9 | 70 (64, 75) | 10 | 8 |
| Deep vein thrombosis | 17 | 9 | 9/9 (100%)†† | 7 | 2 | 67 (63, 75) | 7 | 3 |
| Pulmonary embolism | 7 | 3 | 3/3 (100%) | 0 | 3 | 55 (54, 57) | 3 | 0 |
| Retinal vein thrombosis | 2 | 1 | 0/1 (0%) | - | - | - | - | - |
*
During treatment or within 1 month of stopping.
†
Risk factors: past medical history ischaemic heart disease, diabetes, hypertension, cigarette smoker, obesity, recent surgery, peripheral vascular disease, polymyalgia rheumatica, atrial fibrillation, previous TE event.
‡
Where follow-up received.
§
Five not selected for follow-up: pre-existing disease (3) and fatalities (2), no further information available, one follow-up was a non-event.
¶
One follow-up was a non-event.
**
Five not selected for follow-up: pre-existing disease (2), and fatalities (3), no further information available.
IQR, interquartile range.